Sonoma Biotherapeutics
Developer of T cell therapeutics designed to cure autoimmune and degenerative diseases.
Drug Discovery
📍 San Francisco, CA
Founded 2019
Current Valuation
$715M
as of 2023-Q1
PRIVATE
Developer of T cell therapeutics designed to cure autoimmune and degenerative diseases.
Company Profile
Last Round
Series B1 — $30M (Mar 2023)
Fundraising Status
Series B1 · $30M · 3y 3mo ago
privateTotal raised $365M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series B1 | $30M | Mar 2023 | — | $715M |
BiotechnologyLife ScienceTherapeutics
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2023-Q1. Refreshed quarterly.